For a study, researchers sought to outline the causes and initial signs of periurethral and anterior vaginal wall masses in a sizable patient population in a medical setting.
Between November 2001 and July 2021, 126 patients who presented and received treatment for periurethral and anterior vaginal wall masses underwent a retrospective chart review. Data from clinicopathologic sources were taken. The ethics were approved. The study’s main goal was to identify the cause of these masses; other goals included figuring out the prevalence of symptoms, complications, stress urinary incontinence (SUI) resolution, and de novo SUI.
The patient’s average age was 42. Urinary diverticula (39.7% of cases) and Skene gland cysts or abscesses (30.2%) were the two most frequent causes. Malignancy rates were 1.6%, and infection rates were 21.4%, respectively. The sensation of mass (78.6%), dyspareunia (52.4%), and discharge (46.0%) were the most prevalent presenting symptoms. In addition, 9.5% of surgeries had problems. Following excision, there were no recurring urethral diverticula in any of the three individuals who experienced recurrence. De novo SUI occurred at a rate of 5.6%. All patients with slings stated that their SUI had resolved, with a remission rate of 67.6%.
About 70% of the periurethral and anterior vaginal wall masses in the study were urethral diverticula and Skene gland cysts or abscesses. Complete excision is typically an effective treatment.
